US Stock MarketDetailed Quotes

BDRX Biodexa Pharmaceuticals

Watchlist
  • 1.3200
  • -0.1900-12.58%
Close May 1 16:00 ET
  • 1.3100
  • -0.0100-0.76%
Post 19:26 ET
5.79MMarket Cap-131P/E (TTM)

Biodexa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biodexa Pharmaceuticals Earnings Date

Currency: GBP

Period

FY2023 Annual Report

--

Revenue(YoY)

381.00K

-45.49%
EPS(YoY)

-8.00

+98.71%
Analyst Rating

Buy

Apr 30, 2024

Biodexa Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Sep 30, 20192019/Q2230.000K / 300.000K--
--2019/Q1230.000K / 200.000K--
DatePeriodRevenue/EstimateEarnings Call
Sep 30, 20192019/Q2230.000K / 300.000K--
--2019/Q1230.000K / 200.000K--

Biodexa Pharmaceuticals Earnings Reports

  • Biodexa Pharmaceuticals | 20-F: Registration statement / Annual report / Transition report

    Apr 19 12:49 ET

  • Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 19 08:23 ET

  • Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 21, 2023 16:30 ET

  • Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 27, 2023 08:45 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-1.97%